EP3833381
MODIFIED FACTOR VII POLYPEPTIDES FOR SUBCUTANEOUS ADMINISTRATION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
15.8.2020EP published:
3.8.2022EP application number:
20762011.3
EPO information:
European Patent Register
Max expiry date:
14.8.2040
Title in English:
MODIFIED FACTOR VII POLYPEPTIDES FOR SUBCUTANEOUS ADMINISTRATIONLanguage of the patent:
English
Timeline
Today
15.8.2020EP application
3.8.2022EP Publication
Owner
Name:
Catalyst Biosciences, Inc.Address:
611 Gateway Blvd., Suite 710, South San Francisco, CA 94080, US
Inventor
Name:
BLOUSE, Grant E.Address:
Burlingame, California 94010, US
Name:
KNUDSEN, TomAddress:
Burlingame, California 94010, US
Name:
LEVY, HowardAddress:
Hopewell, New Jersey 08525, US
Priority
Number:
201962887599 PDate:
15.8.2019Country:
US
Number:
202062970152 PDate:
4.2.2020Country:
US
Number:
202063010656 PDate:
15.4.2020Country:
US
Classification
Categories:
A61K 38/48, A61P 7/04